Pegylated interferon alpha-2a plus ribavirin for decompensated hepatitis C virus-related cirrhosis: relationship between efficacy and cumulative dose | |
Wang, Xu; Xu, Yan; Qi, Wenqian; Zhao, Ping; Zhang, Yonggui; Zhang, Qian; Qin, Shaoyou; Wang, Jiangbin | |
刊名 | LIVER INTERNATIONAL |
2014 | |
卷号 | 34期号:10 |
关键词 | cumulative dose decompensated cirrhosis genotype hepatitis C virus virological response |
ISSN号 | 1478-3223 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3518954 |
专题 | 吉林大学白求恩第三医院 |
推荐引用方式 GB/T 7714 | Wang, Xu,Xu, Yan,Qi, Wenqian,et al. Pegylated interferon alpha-2a plus ribavirin for decompensated hepatitis C virus-related cirrhosis: relationship between efficacy and cumulative dose[J]. LIVER INTERNATIONAL,2014,34(10). |
APA | Wang, Xu.,Xu, Yan.,Qi, Wenqian.,Zhao, Ping.,Zhang, Yonggui.,...&Wang, Jiangbin.(2014).Pegylated interferon alpha-2a plus ribavirin for decompensated hepatitis C virus-related cirrhosis: relationship between efficacy and cumulative dose.LIVER INTERNATIONAL,34(10). |
MLA | Wang, Xu,et al."Pegylated interferon alpha-2a plus ribavirin for decompensated hepatitis C virus-related cirrhosis: relationship between efficacy and cumulative dose".LIVER INTERNATIONAL 34.10(2014). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论